Sanofi says myelofibrosis treatment study positive
PARIS (Reuters) - French drugmaker Sanofi said a late-stage Phase III trial of a drug designed to treat myelofibrosis led to positiv...
Read More »PARIS (Reuters) - French drugmaker Sanofi said a late-stage Phase III trial of a drug designed to treat myelofibrosis led to positiv...
Read More »By Sharon Begley NEW YORK (Reuters) - The long-awaited, controversial new edition of the bible of psychiatry can be characterized by...
Read More »By Kate Kelland LONDON (Reuters) - British fertility experts have devised a new IVF technique that takes thousands of snapshots of a...
Read More »By David Morgan WASHINGTON (Reuters) - The Republican-controlled U.S. House of Representatives voted to repeal President Barack Obam...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - People who've sustained multiple brain injuries throughout their life were more like...
Read More »By Atossa Araxia Abrahamian NEW YORK (Reuters) - Up to 20 percent of children in the United States suffer from a mental disorder, an...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Being under stress at work is tied to a higher risk of heart problems, new research c...
Read More »By Bill Berkrot (Reuters) - An experimental leukemia treatment that Roche Holding AG hopes will improve upon its best-selling cancer...
Read More »By Kerry Grens NEW YORK (Reuters Health) - Men who die of a sudden cardiac event are less likely to do so on the first day of mounta...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - Adding a plant-derived compound called a sterol to the cholesterol-lowering agent red y...
Read More »